(Q41158885)

reason for preferred rank

27 September 2017

title

Drugs, sex and HIV : a mathematical model for New York City (English)

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

26 October 2022

Drugs, sex and HIV: a mathematical model for New York City (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674152

26 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674152

26 October 2022

mathematical model

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674152

26 October 2022

4

Anderson RM

1 reference

27 September 2017

Blower SM

1

1 reference

27 September 2017

Hartel D

2

1 reference

27 September 2017

Dowlatabadi H

3

1 reference

27 September 2017

May RM

5

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 February 1991

1 reference

27 September 2017

28 February 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1674152

full work available at URL

26 October 2022

https://royalsocietypublishing.org/doi/pdf/10.1098/rstb.1991.0006

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Philosophical Transactions of the Royal Society B

26 October 2022

published in

1 reference

27 September 2017

volume

331

1 reference

27 September 2017

issue

1260

1 reference

27 September 2017

page(s)

171-187

1 reference

Epidemiological parameters of HIV transmission

27 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Possible demographic consequences of AIDS in developing countries

26 October 2022

3

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Incubation periods for paediatric AIDS patients

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Incubation period of AIDS in San Francisco

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Predictors of the survival of AIDS cases in Barcelona, Spain

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

26 October 2022

HIV, drugs, and ecology.

10

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

The Epidemiology of HIV Infection in Children and Their Mothers—Vertical Transmission

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Distribution of Risk Behaviour for HIV Infection Amongst Intravenous Drug Users

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial

26 October 2022

15

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Epidemiology of HIV infection and AIDS in the United States

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Heterosexual partners: a large risk group for AIDS

26 October 2022

18

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

HIV and intravenous drug use.

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Heroin activity in New York City, 1970-1978.

26 October 2022

24

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

AIDS and addiction in New York City

26 October 2022

28

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Estimating population prevalence of human immunodeficiency virus infection in urban areas with high rates of intravenous drug use: a model of the Bronx in 1988.

26 October 2022

29

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

MOTHER-TO-CHILD TRANSMISSION OF HIV INFECTION

26 October 2022

30

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Risk factors for male to female transmission of HIV. European Study Group

26 October 2022

31

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users

26 October 2022

32

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

26 October 2022

34

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Seeking truth in heroin indicators: the case of New York City

26 October 2022

35

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns

26 October 2022

36

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Transmission of the human immunodeficiency virus

26 October 2022

37

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

AIDS and self-organization among intravenous drug users

26 October 2022

38

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members

26 October 2022

41

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120.

26 October 2022

42

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine

26 October 2022

43

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988.

26 October 2022

46

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

26 October 2022

47

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Needlestick and needleshare--the difference.

26 October 2022

48

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Heterosexual transmission of HIV

26 October 2022

53

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Estimating the incubation period for AIDS patients

26 October 2022

55

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

26 October 2022

57

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

A model-based estimate of the mean incubation period for AIDS in homosexual men

26 October 2022

59

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus

26 October 2022

60

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Transmission dynamics of HIV infection

26 October 2022

61

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Incubation period of AIDS in patients infected via blood transfusion.

26 October 2022

64

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Estimating the incubation period for AIDS patients

26 October 2022

65

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

The distribution of the incubation period for the acquired immunodeficiency syndrome (AIDS).

26 October 2022

66

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters

26 October 2022

72

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City

26 October 2022

74

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

The epidemiology of perinatal transmission of HIV.

26 October 2022

75

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Risk factors for human immunodeficiency virus infection in intravenous drug users

26 October 2022

79

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Survival in children with perinatally acquired human immunodeficiency virus type 1 infection

26 October 2022

80

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS.

26 October 2022

82

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

26 October 2022

86

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City

26 October 2022

90

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Incidence of seroconversion and progression of HIV disease among intravenous drug abusers

26 October 2022

93

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

26 October 2022

94

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

26 October 2022

95

1 reference

https://api.crossref.org/works/10.1098/RSTB.1991.0006

26 October 2022

Identifiers

1 reference

27 September 2017

1 reference